Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients.

1,25-dihydroxyvitamin D 25-hydroxyvitamin D intact parathyroid hormone non-oxidized parathyroid hormone oxidized parathyroid hormone parathyroid hormone

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 02 03 2023
accepted: 17 05 2023
medline: 19 6 2023
pubmed: 16 6 2023
entrez: 16 6 2023
Statut: epublish

Résumé

25-hydroxyvitamin D (25(OH)D) and potentially also 1,25-dihydroxyvitamin D (1,25(OH)2D) inhibits the synthesis of parathyroid hormone (PTH) in the chief cells of the parathyroid gland. Clinical studies showing a negative correlation between (25(OH)D and PTH are in good agreement with these findings in basic science studies. However, PTH was measured in these studies with the currently clinically used 2nd or 3rd generation intact PTH (iPTH) assay systems. iPTH assays cannot distinguish between oxidized forms of PTH and non-oxidized PTH. Oxidized forms of PTH are the by far most abundant form of PTH in the circulation of patients with impaired kidney function. Oxidation of PTH causes a loss of function of PTH. Given that the clinical studies done so far were performed with an PTH assay systems that mainly detect oxidized forms of PTH, the real relationship between bioactive non-oxidized PTH and 25(OH)D as well as 1,25(OH)2D is still unknown. To address this topic, we compared for the first time the relationship between 25(OH)D as well as 1,25(OH)2D and iPTH, oxPTH as well as fully bioactive n-oxPTH in 531 stable kidney transplant recipients in the central clinical laboratories of the Charité. Samples were assessed either directly (iPTH) or after oxPTH (n-oxPTH) was removed using a column that used anti-human oxPTH monoclonal antibodies, a monoclonal rat/mouse parathyroid hormone antibody (MAB) was immobilized onto a column with 500 liters of plasma samples. Spearman correlation analysis and Multivariate linear regression were used to evaluate the correlations between the variables. There was an inverse correlation between 25(OH)D and all forms of PTH, including oxPTH (iPTH: r=-0.197, p<0.0001; oxPTH: r=-0.203, p<0.0001; n-oxPTH: r=-0.146, p=0.001). No significant correlation was observed between 1,25(OH)2D and all forms of PTH. Multiple linear regression analysis considering age, PTH (iPTH, oxPTH and n-oxPTH), serum calcium, serum phosphor, serum creatinine, fibroblast growth factor 23 (FGF23), osteoprotegerin (OPG), albumin, and sclerostin as confounding factors confirmed these findings. Subgroup analysis showed that our results are not affected by sex and age. In our study, all forms of PTH are inversely correlated with 25-hydroxyvitamin D (25(OH)D). This finding would be in line with an inhibition of the synthesis of all forms of PTH (bioactive n-oxPTH and oxidized forms of PTH with minor or no bioactivity) in the chief cells of the parathyroid glad.

Sections du résumé

Background UNASSIGNED
25-hydroxyvitamin D (25(OH)D) and potentially also 1,25-dihydroxyvitamin D (1,25(OH)2D) inhibits the synthesis of parathyroid hormone (PTH) in the chief cells of the parathyroid gland. Clinical studies showing a negative correlation between (25(OH)D and PTH are in good agreement with these findings in basic science studies. However, PTH was measured in these studies with the currently clinically used 2nd or 3rd generation intact PTH (iPTH) assay systems. iPTH assays cannot distinguish between oxidized forms of PTH and non-oxidized PTH. Oxidized forms of PTH are the by far most abundant form of PTH in the circulation of patients with impaired kidney function. Oxidation of PTH causes a loss of function of PTH. Given that the clinical studies done so far were performed with an PTH assay systems that mainly detect oxidized forms of PTH, the real relationship between bioactive non-oxidized PTH and 25(OH)D as well as 1,25(OH)2D is still unknown.
Methods UNASSIGNED
To address this topic, we compared for the first time the relationship between 25(OH)D as well as 1,25(OH)2D and iPTH, oxPTH as well as fully bioactive n-oxPTH in 531 stable kidney transplant recipients in the central clinical laboratories of the Charité. Samples were assessed either directly (iPTH) or after oxPTH (n-oxPTH) was removed using a column that used anti-human oxPTH monoclonal antibodies, a monoclonal rat/mouse parathyroid hormone antibody (MAB) was immobilized onto a column with 500 liters of plasma samples. Spearman correlation analysis and Multivariate linear regression were used to evaluate the correlations between the variables.
Results UNASSIGNED
There was an inverse correlation between 25(OH)D and all forms of PTH, including oxPTH (iPTH: r=-0.197, p<0.0001; oxPTH: r=-0.203, p<0.0001; n-oxPTH: r=-0.146, p=0.001). No significant correlation was observed between 1,25(OH)2D and all forms of PTH. Multiple linear regression analysis considering age, PTH (iPTH, oxPTH and n-oxPTH), serum calcium, serum phosphor, serum creatinine, fibroblast growth factor 23 (FGF23), osteoprotegerin (OPG), albumin, and sclerostin as confounding factors confirmed these findings. Subgroup analysis showed that our results are not affected by sex and age.
Conclusion UNASSIGNED
In our study, all forms of PTH are inversely correlated with 25-hydroxyvitamin D (25(OH)D). This finding would be in line with an inhibition of the synthesis of all forms of PTH (bioactive n-oxPTH and oxidized forms of PTH with minor or no bioactivity) in the chief cells of the parathyroid glad.

Identifiants

pubmed: 37324252
doi: 10.3389/fendo.2023.1178166
pmc: PMC10264784
doi:

Substances chimiques

Parathyroid Hormone 0
Calcifediol P6YZ13C99Q

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1178166

Informations de copyright

Copyright © 2023 Zuo, Hasan, Hocher, Kalk, Kleuser, Krämer and Hocher.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nutrients. 2019 Aug 01;11(8):
pubmed: 31374914
Eur J Endocrinol. 2006 Aug;155(2):237-44
pubmed: 16868136
Clin Chim Acta. 2020 Sep;508:92-97
pubmed: 32413401
Mol Endocrinol. 2003 May;17(5):777-91
pubmed: 12637589
J Clin Endocrinol Metab. 2013 Jul;98(7):2922-8
pubmed: 23633202
Am J Clin Nutr. 2010 Jul;92(1):69-76
pubmed: 20484452
Osteoporos Int. 2016 Feb;27(2):617-26
pubmed: 26359185
J Clin Endocrinol Metab. 2015 Oct;100(10):3814-21
pubmed: 26241322
Adv Nutr. 2017 Nov 15;8(6):947-957
pubmed: 29141976
J Cell Mol Med. 2020 Jul;24(13):7370-7377
pubmed: 32415728
Nutrients. 2019 Jun 04;11(6):
pubmed: 31167443
J Bone Miner Res. 1988 Jun;3(3):353-8
pubmed: 3213628
Int Urol Nephrol. 2021 May;53(5):973-983
pubmed: 33420892
Kidney Int. 2016 Dec;90(6):1184-1190
pubmed: 27653840
J Biol Chem. 1984 May 10;259(9):5507-13
pubmed: 6715358
N Engl J Med. 1997 Sep 4;337(10):670-6
pubmed: 9278463
Nature. 1970 Nov 21;228(5273):764-6
pubmed: 4319631
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
J Clin Invest. 2007 Dec;117(12):4003-8
pubmed: 17992255
Clin Chem. 2009 Aug;55(8):1584-5
pubmed: 19541868
PLoS One. 2012;7(7):e40242
pubmed: 22792251
Arch Biochem Biophys. 1986 Feb 1;244(2):641-9
pubmed: 3947084
Lancet. 1998 Mar 14;351(9105):805-6
pubmed: 9519960
Biochim Biophys Acta. 2005 Jan 17;1703(2):213-9
pubmed: 15680229
Nutrients. 2020 Mar 27;12(4):
pubmed: 32230847
J Clin Endocrinol Metab. 1999 Jun;84(6):2151-6
pubmed: 10372724
J Intern Med. 2012 Jun;271(6):573-80
pubmed: 21995281
Endocr Connect. 2019 May 01;8(5):518-527
pubmed: 30959477
Nutrients. 2020 Mar 28;12(4):
pubmed: 32231092
Clin Chem Lab Med. 2018 Jan 26;56(2):249-255
pubmed: 28809747
PLoS One. 2021 Oct 14;16(10):e0258585
pubmed: 34648586
Exp Gerontol. 2019 Nov;127:110735
pubmed: 31520697
Nephrology (Carlton). 2016 Jun;21(6):483-9
pubmed: 26428957
J Clin Invest. 1981 Mar;67(3):885-92
pubmed: 7204561
J Clin Endocrinol Metab. 2009 Oct;94(10):4023-30
pubmed: 19584181
Rev Endocr Metab Disord. 2017 Sep;18(3):307-322
pubmed: 28214921
Int J Environ Res Public Health. 2021 Dec 10;18(24):
pubmed: 34948669
Proc Natl Acad Sci U S A. 1985 Jun;82(12):4270-3
pubmed: 3858880
J Lipid Res. 2014 Jan;55(1):13-31
pubmed: 23564710
Metabolism. 2020 Apr;105:154138
pubmed: 31923385
BMC Nephrol. 2021 Apr 8;22(1):125
pubmed: 33832449
Am J Clin Nutr. 2008 Apr;87(4):1087S-91S
pubmed: 18400739
N Engl J Med. 1998 Mar 19;338(12):777-83
pubmed: 9504937
J Clin Endocrinol Metab. 2002 Jun;87(6):2967-72
pubmed: 12050281
Int J Vitam Nutr Res. 1996;66(1):39-45
pubmed: 8698545
Clin Chim Acta. 2020 Jul;506:84-91
pubmed: 32178977
J Clin Endocrinol Metab. 2010 Feb;95(2):471-8
pubmed: 20133466
J Clin Endocrinol Metab. 2003 Jan;88(1):185-91
pubmed: 12519850
Endocrine. 2015 Aug;49(3):800-8
pubmed: 25681052
J Clin Endocrinol Metab. 2014 Apr;99(4):1367-74
pubmed: 24285680
Rev Med Chir Soc Med Nat Iasi. 2015 Apr-Jun;119(2):310-8
pubmed: 26204630
J Clin Endocrinol Metab. 2005 Oct;90(10):5576-81
pubmed: 16076940
Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):669-684
pubmed: 30449548
J Nutr Health Aging. 2018;22(9):1045-1050
pubmed: 30379301
J Clin Endocrinol Metab. 2005 Jun;90(6):3215-24
pubmed: 15797954
Clin J Am Soc Nephrol. 2018 Apr 6;13(4):524-526
pubmed: 29507007
J Clin Endocrinol Metab. 2012 Nov;97(11):3989-95
pubmed: 22933544
Clin Nephrol. 2021 Sep;96(3):129-137
pubmed: 34042584
Kidney Blood Press Res. 2013;37(4-5):240-51
pubmed: 23868100
J Biol Chem. 1990 Apr 5;265(10):5671-6
pubmed: 2318832
Clin Nutr. 2021 May;40(5):3305-3313
pubmed: 33190990
J Clin Invest. 1989 Apr;83(4):1349-55
pubmed: 2703535
J Biol Chem. 2004 Apr 16;279(16):16754-66
pubmed: 14739296
Clin Exp Nephrol. 2020 Dec;24(12):1177-1183
pubmed: 32816133
J Steroid Biochem Mol Biol. 2022 Jun;220:106101
pubmed: 35351538
N Engl J Med. 2012 Dec 27;367(26):2482-94
pubmed: 23121374
Int J Mol Sci. 2022 Oct 13;23(20):
pubmed: 36293083
FEBS Lett. 1993 Jul 12;326(1-3):285-8
pubmed: 8325381
Kidney Dis (Basel). 2017 Jul;3(1):8-14
pubmed: 28785559
Osteoporos Int. 2003 Apr;14(2):152-9
pubmed: 12730772
FASEB J. 2020 Nov;34(11):15269-15281
pubmed: 32964520

Auteurs

Jiao Zuo (J)

Department of Nephrology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology, Pneumonology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.

Ahmed A Hasan (AA)

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology, Pneumonology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.

Carl-Friedrich Hocher (CF)

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology, Pneumonology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
Klinik für Innere Medizin, Bundeswehrkrankenhaus Berlin, Berlin, Germany.

Philipp Kalk (P)

Department of Nephrology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Diaverum Renal Care Center, Diaverum MVZ Am Neuen Garten Standort Ludwigsfelde, Potsdam, Germany.

Burkhard Kleuser (B)

Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.

Bernhard K Krämer (BK)

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology, Pneumonology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
European Center for Angioscience ECAS, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany.

Berthold Hocher (B)

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology, Pneumonology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Reproductive, Genetic Hospital of CITIC-Xiangya, Changsha, China.
Institute of Medical Diagnostics, IMD, Berlin, Germany.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH